With commercial insurance · as little as$60for a month of sensors
Commercial insurance with pharmacy coverage for the sensor only; the program pays at most $380 a month and $2,000 a year. Not for Medicare, Medicaid, VA or TRICARE, and not in Massachusetts or Michigan.
Percutaneous interstitial fluid glucose monitoring system, electrochemical. An assembly of electrically-powered, portable devices intended to continuously monitor interstitial fluid glucose concentrations in a patient with diabetes mellitus, using an invasive electrochemical technique. It consists of an electrochemical, percutaneously-inserted electrode that physically connects to a cable or transmitter which communicates with a monitor or receiver (not included) that captures, stores, and converts the sensor signals to glucose concentrations for display. The system may be used in the home and clinical settings, and aids in the detection of episodes of hyperglycaemia and hypoglycaemia, facilitating acute/long-term therapy adjustments.
Sensor, glucose, invasive, non-adjunctive. A non-adjunctive invasive glucose sensor is intended to determine glucose levels, and the direction and rate of change of glucose levels in people with diabetes. The device is indicated to replace information obtained from standard blood glucose monitoring devices to make diabetes-related treatment decisions. The device also provides historical glucose information, facilitating long-term therapy adjustments.
Only your prescriber can say whether a device is right for you.
In the FDA’s device database
Needs a prescription.
Its labeling says “MR Unsafe”: it can’t go into an MRI machine. Tell the MRI staff you use it.
Company on its FDA records: Medtronic Minimed. Its support line: +1(800)633-8766.
11 versions sold now
Each opens its FDA record. The model number is on the box.